We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHW icon
51
Sherwin-Williams
SHW
$89.7B
$78.1M 0.48%
511,233
-13,062
-2% -$1.95M
MSCI icon
52
MSCI
MSCI
$41.6B
$77.6M 0.48%
324,902
-178,882
-36% -$40.1M
CHTR icon
53
Charter Communications
CHTR
$18.3B
$76.9M 0.48%
194,514
+59,021
+44% +$22.1M
COP icon
54
ConocoPhillips
COP
$140B
$76.6M 0.48%
1,255,578
+1,076,519
+601% +$67M
BRSL
55
Brightstar Lottery PLC
BRSL
$2.08B
$73.8M 0.46%
5,692,650
+100
+0% +$1.36K
IQV icon
56
IQVIA
IQV
$38.9B
$73.8M 0.46%
458,374
-139,148
-23% -$19.5M
HEI icon
57
HEICO Corp
HEI
$51.3B
$73.1M 0.45%
546,309
-50,381
-8% -$5.6M
CTAS icon
58
Cintas
CTAS
$80.6B
$71.6M 0.44%
1,207,408
-18,324
-1% -$1.01M
ISRG icon
59
Intuitive Surgical
ISRG
$133B
$71.4M 0.44%
408,561
-125,481
-23% -$21.5M
V icon
60
Visa
V
$688B
$71M 0.44%
409,318
-122,945
-23% -$20.1M
LHX icon
61
L3Harris
LHX
$53.3B
$70.5M 0.44%
372,624
+370,924
+21,819% +$66.9M
AAPL icon
62
Apple
AAPL
$4.54T
$67.9M 0.42%
1,371,508
+10,600
+0.8% +$516K
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.12T
$67.8M 0.42%
318,108
+310,000
+3,823% +$64.1M
NFLX icon
64
Netflix
NFLX
$309B
$67.5M 0.42%
1,837,410
+1,586,430
+632% +$57.2M
EW icon
65
Edwards Lifesciences
EW
$51.3B
$67.3M 0.42%
1,093,476
+872,514
+395% +$52.8M
COST icon
66
Costco
COST
$418B
$65M 0.4%
245,804
-66,147
-21% -$16.5M
PGR icon
67
Progressive
PGR
$124B
$64.6M 0.4%
808,405
-583,196
-42% -$45.1M
LMT icon
68
Lockheed Martin
LMT
$133B
$64.3M 0.4%
176,877
+172,789
+4,227% +$57.8M
LRCX icon
69
Lam Research
LRCX
$385B
$63.8M 0.4%
3,394,470
-2,426,590
-42% -$46M
OLLI icon
70
Ollie's Bargain Outlet
OLLI
$4.74B
$63.5M 0.39%
728,653
+223,584
+44% +$21.1M
RHT
71
DELISTED
Red Hat Inc
RHT
$63.2M 0.39%
336,569
-69,744
-17% -$12.9M
ZBRA icon
72
Zebra Technologies
ZBRA
$17.5B
$62.3M 0.39%
297,502
+279,447
+1,548% +$56.3M
ATO icon
73
Atmos Energy
ATO
$28.7B
$61M 0.38%
577,632
– –
VMW
74
DELISTED
VMware, Inc
VMW
$60.3M 0.37%
360,682
+15,818
+5% +$2.96M
NVR icon
75
NVR
NVR
$17B
$60M 0.37%
17,797
+2,539
+17% +$8.14M
1 2
3
4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.